2021
DOI: 10.3390/life11020088
|View full text |Cite
|
Sign up to set email alerts
|

The Emerging Physiological Role of AGMO 10 Years after Its Gene Identification

Abstract: The gene encoding alkylglycerol monooxygenase (AGMO) was assigned 10 years ago. So far, AGMO is the only known enzyme capable of catalysing the breakdown of alkylglycerols and lyso-alkylglycerophospholipids. With the knowledge of the genetic information, it was possible to relate a potential contribution for mutations in the AGMO locus to human diseases by genome-wide association studies. A possible role for AGMO was implicated by genetic analyses in a variety of human pathologies such as type 2 diabetes, neur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 103 publications
0
18
0
Order By: Relevance
“…We then searched for specific hAd7 marker genes that exhibit this same relationship with HOMA-IR, and identified several, including AGMO, ALPK3, FHOD3, and LIN7A (Figure 4f, g). Of note, AGMO (also called TMEM195) has emerged as a candidate locus in T2D GWAS 49,50 .Taken together, our data suggest that hAd7 may have an outsized influence on the risk of T2D, despite representing only ~1% of human adipocytes.…”
Section: Relationships Between Wat Cell Types and Human Diseasementioning
confidence: 66%
“…We then searched for specific hAd7 marker genes that exhibit this same relationship with HOMA-IR, and identified several, including AGMO, ALPK3, FHOD3, and LIN7A (Figure 4f, g). Of note, AGMO (also called TMEM195) has emerged as a candidate locus in T2D GWAS 49,50 .Taken together, our data suggest that hAd7 may have an outsized influence on the risk of T2D, despite representing only ~1% of human adipocytes.…”
Section: Relationships Between Wat Cell Types and Human Diseasementioning
confidence: 66%
“…This revealed that, while in most cases we already had a significant amount of structural data, either experimental (sequence identity > 95%) or through template-based homology (sequence identity > 20%), there are 1,448 proteins with very high structural coverage (PDB sequence identity >20% or pLDDT > 90 for more than 95% of all residues of the protein) where AlphaFold contributes over 50% of the structural data. This is the case of relevant proteins in the biomedical context such as AGMO, an enzyme that has been linked to numerous diseases such as cancer and diabetes [ 30 ], DEGS1, another enzyme with a critical role in lipid metabolism [ 31 ], or PEMT, another lipid metabolism enzyme and was amongst the first genes associated with non-alcoholic fatty liver disease [ 32 ] ( Fig 2E–2G respectively). In all three cases no structural information was known nor any template with enough sequence identity to build a model (sequence identity > 20%).…”
Section: Resultsmentioning
confidence: 99%
“…This revealed that, while in most cases we already had a significant amount of structural data, either experimental (sequence identity > 95%) or through template-based homology (sequence identity > 20%), there are 1,448 proteins with very high structural coverage (PDB sequence identity >20% or pLDDT > 90 for more than 95% of all residues of the protein) where AlphaFold contributes over 50% of the structural data. This is the case of relevant proteins in the biomedical context such as AGMO, an enzyme that has been linked to numerous diseases such as cancer and diabetes[30], DEGS1, another enzyme with a critical role in lipid metabolism[31], or PEMT, another lipid metabolism enzyme and was amongst the first genes associated with non-alcoholic fatty liver disease[32] ( Figure 2e-g respectively). In all three cases no structural information was known nor any template with enough sequence identity to build a model (sequence identity > 20%).…”
Section: Resultsmentioning
confidence: 99%